Chemistry of the mind: Neurochemical modulation of prefrontal cortical function

Journal of Comparative Neurology

Volumn 493, Issue 1, 2005, Pages 140-146

  Robbins, Trevor W ^a,b  

^a UK   (United Kingdom)

^b Department of Experimental Psychology ^*  (United Kingdom)

Author keywords

Attention; Cognition; Dopamine; Monoamines; Prefrontal cortex; Serotonin

Indexed keywords

ACETYLCHOLINE; DOPAMINE; DOPAMINE 1 RECEPTOR; NEUROTRANSMITTER; NORADRENALIN;

ATTENTION; BRAIN FUNCTION; CONFERENCE PAPER; DOPAMINERGIC SYSTEM; HUMAN; IMPULSIVENESS; NEUROCHEMISTRY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; WORKING MEMORY;

ANIMALS; BRAIN CHEMISTRY; DOPAMINE; HUMANS; MODELS, NEUROLOGICAL; PREFRONTAL CORTEX; RATS; RECEPTORS, DOPAMINE D1; SEROTONIN;

EID: 27744473483     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20717     Document Type: Conference Paper

References (48)

1. Amat J, Baratta A, Paul E, Bland ST, Watkins LR, Maier SF. 2005. The ventral medial prefrontal cortex determines how behavioral control over stress impacts behavior and dorsal raphe nucleus activity. Nat Neurosci 8:365-371.
2. Arnsten AFT. 1998. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 2:436-447.
3. Aston-Jones G, Rajkowski J, Cohen J. 1999. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46:1309-1320.
4. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. 1979. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929-932.
5. Chao LL, Knight RT. 1995. Human prefrontal lesions increase distractibility to irrelevant sensory inputs. Neuroreport 6:1605-1610.
6. Cheesman AL, Barker RA, Lewis SJG, Robbins TW, Owen AM, Brooks DR. 2005. Lateralisation of striatal function: evidence from 18F-Dopa PET in Parkinson's disease. J Neurol Neurosurg Psychiatry 76:1204-1210.
7. Chudasama Y, Passetti F, Rhodes SE, Lopian D, Desai A, Robbins TW. 2003. Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146:105-119.
8. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC. 2004. Cognitive inflexibility after prefrontal serotonin depletion. Science 304:878-880.
9. Clarke H, Crofts J, Robbins TW, Roberts AC. 2005. Perseveration in discrimination reversal learning following prefrontal serotonin depletion in the marmoset. J Neurosci 25:532-538.
10. Cools R, Barker RA, Sahakian BJ, Robbins TW. 2001. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 11:1136-1143.
11. Cools R, Clark L, Owen AM, Robbins TW. 2002a. Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci 22:4563-4567.
12. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM. 2002b. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125:584-594.
13. Cools R, Barker RA, Sahakian BJ, Robbins TW. 2003. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 41:1431-1441.
14. Crofts HS, Dalley JW, Collins P, Van Denderen JC, Everitt BJ, Robbins TW, Roberts AC. 2001. Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb Cortex 11:1015-1026.
15. Dalley JW, McGaughy J, O'Connell, MT, Cardinal R, Levita L, Robbins TW. 2001. Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and non-continent performance of a visual attentional task. J Neurosci 21:4908-4914.
16. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW. 2002. Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 26:716-728.
17. Dias R, Robbins TW, Roberts AC. 1996. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380:69-72.
18. Evers EAT, Cools R, Clark L, van der Veen FM, Jolles J, Sahakian BJ, Robbins TW. 2005. Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology 30:1138-1147.
19. Floresco SB, Phillips AG. 2001. Delay-dependent modulation of memory retrieval by infusion of a dopamine D1 agonist into the rat medial prefrontal cortex. Behav Neurosci 115:934-939.
20. Fuster J. 1989. The prefrontal cortex. New York: Raven Press.
21. Goldman-Rakic PS. 1996. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philos Trans R Soc Lend B Biol Sci 351:1445-1453.
22. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW. 2000. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20:1208-1215.
23. Jones B, Mishkin M. 1972. Limbic lesions and the problem of stimulus-reinforcement associations. Exp Neurol 36:362-377.
24. Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM. 1992. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 107:394-404.
25. Lewis D. 2001. The catecholamine innervation of the prefrontal cortex. In: Solanto MV AA, Castellanos FX, editors. Stimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford University Press. p 77-103.
26. Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P. 1991. Distribution of dopaminergic receptors in the primate cerebral cortex-qualititative autoradiographic analysis using [H-3] spiperone and [H-3] SCH23390. Neuroscience 40:657-671.
27. Manes F, Sahakian B, Clark L, Rogers R, Antoun N, Aitken M, Robbins T. 2002. Decision-making processes following damage to the prefrontal cortex. Brain 125:624-639.
28. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR. 2003. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100:6186-6191.
29. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW. 2000. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20:RC65.
30. Mehta MA, Swainson R, Ogilvie AD, Sahakian J, Robbins TW. 2001. Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacology (Berl) 159:10-20.
31. Miller EK, Cohen JD. 2001. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24:167-202.
32. Nolan KA, Bilder RM, Lachman HM, Volavka J. 2004. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry 161:359-361.
33. Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP, Lange KW, Robbins TW. 1992. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115:1727-1751.
34. Pantelis C, Barber EZ, Barnes TRE, Nelson HE, Owen AM, Robbins TW. 1999. A comparison of set-shifting ability in patients with schizophrenia and frontal lobe damage. Schizophr Res 37:251-270.
35. Park SB, Coull JT, McShane RH, Young AH, Sahakian BJ, Robbins TW, Cowen PJ. 1994. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33:575-588.
36. Passetti F, Dalley JW, Robbins TW. 2003. Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology (Berl) 165:136-145.
37. Petrides M, Milner B. 1982. Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man. Neuropsychologia 20:249-262.
38. Phillips AG, Ahn S, Floresco SB. 2004. Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J Neurosci 24:547-553.
39. Rahman S, Sahakian BJ, Hodges JR, Rogers RD, Robbins TW. 1999. Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain 122:1469-1493.
40. Robbins TW. 2000. Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp Brain Res 133:130-138.
41. Roberts AC, Robbins TW, Everitt BJ, Jones GH, Sirkia TE, Wilkinson J, Page K. 1990. The effects of excitotoxic lesions of the basal forebrain on the acquisition, retention and serial reversal of visual discriminations in marmosets. Neuroscience 34:311-329.
42. Roberts AC, Robbins TW, Everitt BJ, Muir JL. 1992. A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in marmosets. Neuroscience 47:251-264.
43. Roberts AC, De Salvia MA, Wilkinson LS, Collins P, Muir JL, Everitt BJ, Robbins TW. 1994. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J Neurosci 14:2531-2544.
44. Rogers RD, Blackshaw AJ, Middleton HC, Matthews K, Hawtin K, Crowley C, Hopwood A, Wallace C, Deakin JF, Sahakian BJ, Robbins TW. 1999. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl) 146:482-491.
45. Rogers RD, Tunbridge EM, Bhagwagar Z, Drevets WC, Sahakian BJ, Carter CS. 2003. Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 28:153-162.
46. Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F. 2004. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14:1100-1109.
47. Swainson R, Rogers RD, Sahakian BJ, Summers BA, Polkey CE, Robbins TW. 2000. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 38:596-612.
48. Winstanley CA, Chudasama Y, Dalley JW, Theobald DE, Glennon JC, Robbins TW. 2003. Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology (Berl) 167:304-314.